VF
ABOS icon

Virtu Financial’s Acumen Pharmaceuticals ABOS Stock Holding History

Virtu Financial’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,922
Closed -$23K – 1565
2025
Q4 		$23K Buy
+10,922
New +$21.7K ﹤0.01% 1398
2024
Q4 		– Sell
-22,255
Closed -$55K – 1475
2024
Q3 		$55K Sell
22,255
-2,147
-9% -$5.82K ﹤0.01% 997
2024
Q2 		$59K Buy
+24,402
New +$77.7K ﹤0.01% 883
2024
Q1 		– Sell
-23,787
Closed -$91K – 1347
2023
Q4 		$91K Buy
+23,787
New +$70.6K 0.01% 1049
2022
Q3 		– Sell
-26,204
Closed -$123K – 1663
2022
Q2 		$123K Buy
+26,204
New +$98.4K 0.01% 892

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Virtu Financial's ABOS Position: Q1 2026 in Review

Virtu Financial sold out of Acumen Pharmaceuticals (ABOS) in Q1 2026, closing a stake of 10,922 shares — an estimated $23K sold.

Virtu Financial first reported a position in ABOS in Q2 2022 and held it in 5 quarters. The position peaked at $123K in Q2 2022. 84 funds tracked by Wall St. Rank hold ABOS as of Q1 2026.

  • Virtu Financial reported no remaining Acumen Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 10,922 Acumen Pharmaceuticals shares in Q1 2026, an estimated $23K.
  • Virtu Financial first reported a position in Acumen Pharmaceuticals in Q2 2022 and held it in 5 quarters.
  • Virtu Financial's Acumen Pharmaceuticals position peaked at $123K in Q2 2022.
  • 84 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.